After the failure of two clinical trials of Pfizer and Johnson & Johnson announced a complete cessation of all research aimed at finding promising drug against Alzheimer's disease. Scientists believe that a cure for this disease exists.
US pharmaceutical companies were looking for a tool that will help alleviate the consequences of the loss of memory Alzheimer . Scientists have conducted tests in two groups of patients. On the one created by the drug they tested, others were given a placebo.
The study found that the drug did not have developed in the patients with no effect. The positive dynamics of the disease in both groups was similar.
For reference:
Alzheimer's disease (dementia of the Alzheimer type) - the disease is the most common form of primary dementia (dementia) late age. It is characterized by gradually increasing deterioration of memory and other intellectual functions. The disease was first described by German psychiatrist A. Alzheimer in 1907. She was later named after him.
Treatment of Alzheimer's disease is considered to be a very promising trend in the pharmaceutical industry. This disease affects millions of older people around the world, and the first one to find an effective remedy for dementia, will go down in history and make a fortune.
Industry News
Go back to the main page
No comments:
Post a Comment